FDA Intends to Take Action Against Non-FDA-Approved GLP-1 Drugs
Today, the U.S. Food and Drug Administration is announcing its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved ...
FDA approves first GLP-1 pill for obesity from Wegovy maker ...
The FDA has approved the first-ever GLP-1 pill from Wegovy maker Novo Nordisk. Novo Nordisk said the starting dose of 1.5 milligrams will be available in early January in pharmacies and via select ...
Is the new GLP-1 weight loss pill right for you? | Novant ...
In December 2025, the Food and Drug Administration (FDA) approved an oral version of Wegovy for obesity — the first time that a GLP-1 medication has been offered in pill form for weight loss.
FDA approves Novo Nordisk's Wegovy® pill, the first and only ...
PLAINSBORO, N.J., Dec. 22, 2025 /PRNewswire/ -- Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy ® pill, the first oral GLP-1 medicine ...
What to Know About Orforglipron Oral GLP-1 | Eli Lilly and ...
Discover frequently asked and common questions about Orforglipron, an oral GLP-1 medication that is in development for type 2 diabetes and obesity by Eli Lilly and Company.
Compound weight-loss drugs are everywhere. The FDA is ...
The FDA intends to remove questionable active ingredients from the GLP-1 drug market. But the agency’s plan could also make it more difficult for legitimate compounders to produce the drugs.
The First GLP-1 Weight-Loss Pill Is Here!
Ro CEO Zach Reitano heralded this launch as “a new era” for GLP-1 care, marking a significant moment where patients throughout the U.S. can access an FDA-approved GLP-1 weight-loss solution in pill …
The first FDA‑approved oral GLP‑1 for weight loss is here
Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via Weight Watchers Med+ from $149 per month for a limited time.